Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (397) 397
Patent (11) 11
Book / eBook (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
Publication (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (231) 231
science & technology (205) 205
life sciences & biomedicine (201) 201
oncology (173) 173
female (144) 144
male (137) 137
middle aged (129) 129
aged (120) 120
adult (100) 100
biological and medical sciences (100) 100
medical sciences (98) 98
tumors (64) 64
cancer (58) 58
chemotherapy (51) 51
aged, 80 and over (49) 49
antineoplastic agents (48) 48
treatment outcome (48) 48
pharmacology. drug treatments (47) 47
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
colorectal neoplasms - drug therapy (38) 38
neoplasms - therapy (33) 33
colorectal cancer (32) 32
clinical trials (31) 31
fluorouracil - administration & dosage (30) 30
neoplasm staging (30) 30
care and treatment (29) 29
neoplasms - drug therapy (29) 29
research (29) 29
decision making (28) 28
prognosis (26) 26
united states (26) 26
antineoplastic agents - therapeutic use (25) 25
colorectal neoplasms - pathology (25) 25
gastroenterology. liver. pancreas. abdomen (25) 25
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
leucovorin - administration & dosage (22) 22
deoxycytidine - analogs & derivatives (21) 21
medical research (21) 21
stomach. duodenum. small intestine. colon. rectum. anus (21) 21
abridged index medicus (19) 19
adenocarcinoma - drug therapy (19) 19
surgery (19) 19
analysis (18) 18
communication (18) 18
patients (18) 18
survival analysis (18) 18
capecitabine (17) 17
health care sciences & services (17) 17
medicine & public health (17) 17
physician-patient relations (17) 17
deoxycytidine - administration & dosage (16) 16
drug administration schedule (16) 16
pharmacology & pharmacy (16) 16
adenocarcinoma - pathology (15) 15
dose-response relationship, drug (15) 15
infusions, intravenous (15) 15
retrospective studies (15) 15
risk factors (15) 15
camptothecin - analogs & derivatives (14) 14
public, environmental & occupational health (14) 14
surveys and questionnaires (14) 14
survival rate (14) 14
combined modality therapy (13) 13
fluorouracil - adverse effects (13) 13
hematology, oncology and palliative medicine (13) 13
neoplasm metastasis (13) 13
antineoplastic agents - adverse effects (12) 12
camptothecin - administration & dosage (12) 12
cohort studies (12) 12
colorectal neoplasms - genetics (12) 12
disease progression (12) 12
disease-free survival (12) 12
informed consent (12) 12
oncology, experimental (12) 12
radiotherapy (12) 12
social sciences (12) 12
antibodies, monoclonal - therapeutic use (11) 11
antibodies, monoclonal, humanized (11) 11
colon cancer (11) 11
colorectal neoplasms - mortality (11) 11
fluorouracil - analogs & derivatives (11) 11
medical oncology (11) 11
medicine, experimental (11) 11
neoplasms (11) 11
neoplasms - economics (11) 11
pancreatic neoplasms - drug therapy (11) 11
patient selection (11) 11
predictive value of tests (11) 11
usage (11) 11
adenocarcinoma - mortality (10) 10
bevacizumab (10) 10
clinical trials as topic (10) 10
cost-benefit analysis (10) 10
health knowledge, attitudes, practice (10) 10
health policy & services (10) 10
maximum tolerated dose (10) 10
pilot projects (10) 10
quality of life (10) 10
risk assessment (10) 10
animals (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
by Bruce J. Giantonio and Paul J. Catalano and Neal J. Meropol and Peter J. O'Dwyer and Edith P. Mitchell and Steven R. Alberts and Michael A. Schwartz and Al B. Benson III and Eastern Cooperative Oncology Group Study E3200
Journal of clinical oncology, ISSN 0732-183X, 04/2007, Volume 25, Issue 12, pp. 1539 - 1544
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Single-Blind Method | Leucovorin - administration & dosage | Follow-Up Studies | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Lung Neoplasms - secondary | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colorectal Neoplasms - mortality | Drug Administration Schedule | Risk Assessment | Probability | Treatment Outcome | Disease Progression | Medical Oncology | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
by Shirin Khambata-Ford and Christopher R. Garrett and Neal J. Meropol and Mark Basik and Christopher T. Harbison and Shujian Wu and Tai W. Wong and Xin Huang and Chris H. Takimoto and Andrew K. Godwin and Benjamin R. Tan and Smitha S. Krishnamurthi and Howard A. Burris III and Elizabeth A. Poplin and Manuel Hidalgo and Jose Baselga and Edwin A. Clark and David J. Mauro
Journal of clinical oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 22, pp. 3230 - 3237
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Glycoproteins - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Epiregulin | Amphiregulin | Antibodies, Monoclonal, Humanized | Intercellular Signaling Peptides and Proteins - metabolism | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | EGF Family of Proteins | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Cetuximab | Glycoproteins - genetics | Enzyme-Linked Immunosorbent Assay | Biomarkers, Tumor - analysis | Epidermal Growth Factor - genetics | Intercellular Signaling Peptides and Proteins - genetics | Proportional Hazards Models | Epidermal Growth Factor - metabolism | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Mutation | Genes, ras | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cost of Cancer Care: Issues and Implications
by Neal J. Meropol and Kevin A. Schulman
Journal of clinical oncology, ISSN 0732-183X, 01/2007, Volume 25, Issue 2, pp. 180 - 186
Health Care Costs - trends | Economics, Medical - trends | Neoplasms - therapy | Neoplasms - economics | Medical Oncology - economics | United States | Biomedical Technology - trends | Humans | Medical Oncology - trends | Neoplasms - prevention & control | Health Policy - economics | Health Expenditures - trends | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Health policy: Overcoming cost barriers to clinical trial participation
by Meropol, Neal J
Nature reviews. Clinical oncology, ISSN 1759-4774, 06/2016, Volume 13, Issue 6, pp. 333 - 334
Health Policy | Humans | Patient Selection | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Delivering affordable cancer care in high-income countries
by Sullivan, Richard, Prof and Peppercorn, Jeffrey, Prof and Sikora, Karol, Prof and Zalcberg, John, Prof and Meropol, Neal J, Prof and Amir, Eitan, MBChB and Khayat, David, MD and Boyle, Peter, Prof and Autier, Philippe, PhD and Tannock, Ian F, Prof and Fojo, Tito, MD and Siderov, Jim, MClinPharm and Williamson, Steve, MRPharmS and Camporesi, Silvia, PhD and McVie, J Gordon, Prof and Purushotham, Arnie D, Prof and Naredi, Peter, Prof and Eggermont, Alexander, Prof and Brennan, Murray F, Prof and Steinberg, Michael L, Prof and De Ridder, Mark, Prof and McCloskey, Susan A, MD and Verellen, Dirk, Prof and Roberts, Terence, MD and Storme, Guy, Prof and Hicks, Rodney J, Prof and Ell, Peter J, Prof and Hirsch, Bradford R, MD and Carbone, David P, Prof and Schulman, Kevin A, Prof and Catchpole, Paul, PhD and Taylor, David, Prof and Geissler, Jan, PhD and Brinker, Nancy G and Meltzer, David, Prof and Kerr, David, Prof and Aapro, Matti, Prof
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 10, pp. 933 - 980
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Health Expenditures - legislation & jurisprudence | Neoplasms - economics | Delivery of Health Care, Integrated - legislation & jurisprudence | Health Care Costs - legislation & jurisprudence | United States | Europe | Humans | Health Services Accessibility - legislation & jurisprudence | Neoplasms - diagnosis | Models, Economic | Health Care Reform - economics | Health Services Misuse - economics | Health Services Research | Socioeconomic Factors | Cost Savings | Health Services Accessibility - economics | Neoplasms - therapy | Healthcare Disparities - economics | Delivery of Health Care, Integrated - economics | Cost-Benefit Analysis | Australia | Health Policy - economics | Insurance, Health - economics | Drugs | Medical colleges | Care and treatment | Oncology, Experimental | Leukemia | Radiation | Research | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
by Steven J. Cohen and Cornelis J.A. Punt and Nicholas Iannotti and Bruce H. Saidman and Kert D. Sabbath and Nashat Y. Gabrail and Joel Picus and Michael Morse and Edith Mitchell and M. Craig Miller and Gerald V. Doyle and Henk Tissing and Leon W.M.M. Terstappen and Neal J. Meropol
Journal of clinical oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 19, pp. 3213 - 3221
Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Prognosis | Prospective Studies | Neoplastic Cells, Circulating - pathology | Humans | Middle Aged | Male | Survival Rate | Chi-Square Distribution | Colorectal Neoplasms - diagnosis | Disease Progression | Diagnostic Imaging | Disease-Free Survival | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Aged | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
by Leonard B. Saltz and Neal J. Meropol and Patrick J. Loehrer Sr and Michael N. Needle and Justin Kopit and Robert J. Mayer
Journal of clinical oncology, ISSN 0732-183X, 04/2004, Volume 22, Issue 7, pp. 1201 - 1208
Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Survival Rate | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Colorectal Neoplasms - therapy | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Agents - adverse effects | Immunotherapy | Aged, 80 and over | Adult | Female | Aged | Infusions, Intravenous | Cetuximab | Colorectal Neoplasms - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ongoing challenge of stage II colon cancer
by Meropol, Neal J
Journal of clinical oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 25, pp. 3346 - 3348
Life Sciences & Biomedicine | Oncology | Science & Technology | Colonic Neoplasms - mortality | Colonic Neoplasms - drug therapy | Humans | Female | Male | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Overcoming cost barriers to clinical trial participation
by Meropol, Neal J
Nature reviews. Clinical oncology, ISSN 1759-4774, 06/2016, Volume 13, Issue 6, pp. 333 - 334
Life Sciences & Biomedicine | Oncology | Science & Technology | Care and treatment | Oncology, Experimental | Clinical trials | Economic aspects | Self-experimentation in medicine | Influence | Forecasts and trends | Research | Social aspects | Human experimentation in medicine | Medical care, Cost of | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
by Martee L. Hensley and Karen L. Hagerty and Tarun Kewalramani and Daniel M. Green and Neal J. Meropol and Todd H. Wasserman and Gary I. Cohen and Bahman Emami and William J. Gradishar and R. Brian Mitchell and J. Tate Thigpen and Andy Trotti III and Daniel von Hoff and Lynn M. Schuchter
Journal of clinical oncology, ISSN 0732-183X, 01/2009, Volume 27, Issue 1, pp. 127 - 145
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Fibroblast Growth Factor 7 - therapeutic use | Antineoplastic Agents - adverse effects | Humans | Radiation-Protective Agents - therapeutic use | Amifostine - therapeutic use | Neoplasms - radiotherapy | Mesna - therapeutic use | Razoxane - therapeutic use | Neoplasms - drug therapy | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
by Neal J. Meropol and Deborah Schrag and Thomas J. Smith and Therese M. Mulvey and Robert M. Langdon, Jr and Diane Blum and Peter A. Ubel and Lowell E. Schnipper and American Society of Clinical Oncology
Journal of clinical oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3868 - 3874
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Education, Medical, Continuing | Neoplasms - economics | United States | Drug Industry | Humans | Physician-Patient Relations | Neoplasms - diagnosis | Evidence-Based Medicine | Antineoplastic Agents - economics | Insurance Coverage | Drug Costs - trends | Health Care Costs - trends | Medical Oncology | Neoplasms - therapy | Societies, Medical | Cost-Benefit Analysis | Biomedical Technology - economics | Insurance, Health | Communication | Patient Education as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights